Exact Bayesian Inference Comparing Binomial Proportions, With Application to Proof-of-Concept Clinical Trials

被引:0
|
作者
Oleksandr Sverdlov
Yevgen Ryeznik
Sheng Wu
机构
[1] One Health Plaza,Integrated Information Sciences, Novartis Institutes for Biomedical Research
[2] Uppsala University,Department of Mathematics
[3] University of California at Los Angeles,Department of Biostatistics, Fielding School of Public Health
关键词
adaptive design; Bayesian methods; numerical integration; R; proof of concept; two independent binomial proportions;
D O I
暂无
中图分类号
学科分类号
摘要
The authors revisit the problem of exact Bayesian inference comparing two independent binomial proportions. Numerical integration in R is used to compute exact posterior distribution functions, probability densities, and quantiles of the risk difference, relative risk, and odds ratio. An application of the methodology is given in the context of randomized comparative proof-of-concept clinical trials that are driven by evaluation of quantitative criteria combining statistical significance and clinical relevance. A two-stage adaptive design based on predictive probability of success is proposed and its operating characteristics are studied via Monte Carlo simulation. The authors conclude that exact Bayesian methods provide an elegant and efficient way to facilitate design and analysis of proof-of-concept studies.
引用
收藏
页码:163 / 174
页数:11
相关论文
共 50 条
  • [1] Exact Bayesian Inference Comparing Binomial Proportions, With Application to Proof-of-Concept Clinical Trials
    Sverdlov, Oleksandr
    Ryeznik, Yevgen
    Wu, Sheng
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (01) : 163 - 174
  • [2] Bayesian Design of Proof-of-Concept Trials
    Fisch, Roland
    Jones, Ieuan
    Jones, Julie
    Kerman, Jouni
    Rosenkranz, Gerd Karl
    Schmidli, Heinz
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (01) : 155 - 162
  • [3] Bayesian Design of Proof-of-Concept Trials
    Roland Fisch
    Ieuan Jones
    Julie Jones
    Jouni Kerman
    Gerd Karl Rosenkranz
    Heinz Schmidli
    [J]. Therapeutic Innovation & Regulatory Science, 2015, 49 : 155 - 162
  • [4] A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints
    Zhang, Wen
    Laird, Glen
    Chen, Josh
    Yuan, Ying
    [J]. STATISTICS IN MEDICINE, 2024, 43 (01) : 173 - 183
  • [5] A Bayesian paradigm for decision-making in proof-of-concept trials
    Pulkstenis, Erik
    Patra, Kaushik
    Zhang, Jianliang
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (03) : 442 - 456
  • [6] Elephants, Parkinson's Disease, and Proof-of-Concept Clinical Trials
    Cedarbaum, Jesse M.
    [J]. MOVEMENT DISORDERS, 2018, 33 (05) : 697 - 700
  • [7] A QUASI-EXACT TEST FOR COMPARING 2 BINOMIAL PROPORTIONS
    HIRJI, KF
    TAN, SJ
    ELASHOFF, RM
    [J]. STATISTICS IN MEDICINE, 1991, 10 (07) : 1137 - 1153
  • [8] EXACT PROPERTIES OF SOME EXACT TEST STATISTICS FOR COMPARING 2 BINOMIAL PROPORTIONS
    STORER, BE
    KIM, C
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1990, 85 (409) : 146 - 155
  • [9] Bayesian Sample Size Calculations for Comparing Two Binomial Proportions
    Zhao Zhanping
    Chen Rong jiang
    Tang Niansheng
    [J]. RECENT ADVANCE IN STATISTICS APPLICATION AND RELATED AREAS, PTS 1 AND 2, 2008, : 481 - +
  • [10] Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis
    Maureen Turina
    Nataliya Yeremenko
    Jacqueline Paramarta
    Bernard Vandooren
    Paul Peter Tak
    Leen De Rycke
    Dominique Baeten
    [J]. Journal of Translational Medicine, 9 (Suppl 2)